SON DAKİKA
--:--:--

Xometry Inc. Announces Convertible Senior Notes Issuance

0 Yorum Yapıldı
Bağlantı kopyalandı!
Xometry Inc. Announces Convertible Senior Notes Issuance

Xometry Inc. to Issue $225 Million in Convertible Senior Notes

Xometry Inc. (NASDAQ:XMTR), renowned for its AI-powered marketplace for on-demand manufacturing services, is set to issue $225 million in Convertible Senior Notes due 2030. This strategic financial move aims to bolster the company’s capital resources and facilitate its growth plans.

These bonds, designed as unsecured obligations of the company, will carry interest payments on a semi-annual basis. Importantly, Xometry is offering initial purchasers the option to buy an additional $25 million in bonds within 13 days from the issuance date, enhancing investment flexibility.

Upon conversion, Xometry has the discretion to settle in cash, Class A common shares, or a combination thereof. The exact interest rate and initial conversion rate are to be determined during the pricing phase.

Strategic Use of Proceeds

Xometry plans to allocate the net proceeds towards several strategic initiatives:

  • Funding the cost of cap-priced option transactions.
  • Repurchasing up to $25 million of Class A common stock in conjunction with the note issuance.
  • Purchasing a portion of its outstanding 1.00% Convertible Senior Notes due 2027.

Should the additional bond purchase option be exercised, Xometry intends to use the extra funds for further cap-priced option transactions, working capital, and potential acquisitions or strategic investments, though no specific agreements are in place yet.

Implications for Shareholders

In conjunction with the notes pricing, Xometry plans to enter into cap-priced option transactions. These are designed to minimize dilution risks from potential note conversions or to offset any excess cash obligations upon conversion. The initial hedging of these options and subsequent market adjustments by option counterparties may impact Xometry’s Class A common shares and bond market prices.

These strategic financial maneuvers, including cap-priced option transactions and share repurchases, are part of Xometry’s efforts to manage its capital structure and protect shareholder value amidst increased debt levels.

This announcement was crafted with the aid of artificial intelligence and subsequently reviewed by an editor. Visit our Terms and Conditions for further details.

Reklam 258Reklam 172ffReklam 585Reklam 231

Yorum Yap

Benzer Haberler
Helsinki Airport Reopens After Three-Hour Closure Over Suspected Drone
Helsinki Airport Reopens After Three-Hour Closure Over Suspected Drone
Marco Rubio Addresses Social Media Debate Over Grey Nike Tracksuit During China Visit
Marco Rubio Addresses Social Media Debate Over Grey Nike Tracksuit During China Visit
Trump Concludes Two-Day Visit to China After Talks With Xi Jinping
Trump Concludes Two-Day Visit to China After Talks With Xi Jinping
Global Sumud Fleet Resumes Journey to Gaza After Previous Israeli Intervention
Global Sumud Fleet Resumes Journey to Gaza After Previous Israeli Intervention
Ukraine Prioritises AI-Powered Drone Swarms in Defence Strategy
Ukraine Prioritises AI-Powered Drone Swarms in Defence Strategy
Iran Says It Is Trying to Preserve Ceasefire to Keep Diplomacy Open
Iran Says It Is Trying to Preserve Ceasefire to Keep Diplomacy Open
En Güncel ve Doğru Haberler!
Sigorta Haber

Sigortahaber.com, sigorta sektöründeki en güncel haberleri, analizleri ve gelişmeleri tarafsız bir bakış açısıyla sunan bağımsız bir haber platformudur. Sigorta profesyonellerine, acentelere ve sektöre ilgi duyan herkese doğru, hızlı ve güvenilir bilgi sağlamayı amaçlıyoruz. Sigortacılıktaki yenilikleri, mevzuat değişikliklerini ve sektör trendlerini yakından takip ederek, okuyucularımıza kapsamlı bir bilgi kaynağı sunuyoruz.

2025 Sigorta Haber © Tüm hakları saklıdır. Sitemizde yer alan Ekonomi ve Finans kategorilerindeki içerikler yalnızca bilgilendirme amaçlıdır; herhangi bir yatırım tavsiyesi niteliği taşımaz. Sağlık ve Bilgi kategorisinde bulunan içerikler genel olarak yapay zekâ tarafından üretilmiş olup yalnızca bilgilendirme amacı taşır. Herhangi bir sağlık sorunu yaşıyorsanız, burada yer alan bilgileri esas almak yerine en kısa sürede uzman bir doktora başvurmanız önerilir.